Drugs Made In America Acquisition Corp.
DMAAU- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $122.3K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Drugs Made In America Acquisition Corp. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 15 | 9 | −6 |
| Shares | 3.29M | 986.1K | −2.30M (−70.0%) |
| Value | $33.4M | $10.2M | −$23.2M (−69.5%) |
New holders (1)
Institutions that held Drugs Made In America Acquisition Corp. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Robinson Capital Management, LLC | 30,000 | $309.6K | 0.13% |
Sold out (7)
Institutions that held Drugs Made In America Acquisition Corp. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Heights Capital Management, Inc | 650,000 | $6.58M |
| Boothbay Fund Management, LLC | 603,750 | $6.14M |
| Westchester Capital Management, LLC | 500,000 | $5.06M |
| Schonfeld Strategic Advisors LLC | 234,831 | $2.39M |
| Parallax Volatility Advisers, L.P. | 100,000 | $1.02M |
| Verition Fund Management LLC | 100,000 | $1.01M |
| Murchinson Ltd. | 90,000 | $915.3K |